Objectives: To describe the prevalence of lamellar hole-associated epiretinal proliferation (LHEP) and to correlate this finding with lamellar macular hole (LMH) morphology and prognosis after a surgical or conservative approach. Methods: This is a retrospective multicenter case series comprising consecutive LMH patients followed for ≥6 months. Serial spectral-domain optical coherence tomographies were evaluated for the presence of epiretinal membrane (ERM) and LHEP, diameter of the LMH aperture, base, and floor thickness. Pars plana vitrectomy with ERM and internal limiting membrane peeling was performed in the surgical cases. Results: A total of 62 eyes from 57 consecutive patients were included. Mean follow-up time was 27.1 ± 19.8 months. LHEP was observed in 33 (53.2%) eyes. Patients with LMH and LHEP presented a larger external diameter (p = 0.001) and thinner floors (p = 0.018). Twenty-seven (81.8%) of the patients with LMH and LHEP presented a degenerative intraretinal cavitation, compared to 23.3% in the non-LHEP group (p = 0.001). No differences were observed in visual performance or closure rate between the 2 groups after surgery or in the subset of patients followed conservatively. Conclusions: LHEP was correlated with the anatomical conformation of the LMH, yielding thinner floors and larger external diameters. However, it did not correlate with the anatomical or functional results, both in the patients who underwent surgery and in those managed conservatively.

Keywords:
Diseases of the retina and vitreous, Image analysis, Macular hole, Optical coherence tomography
1.
Gass JD: Lamellar macular hole: a complication of cystoid macular edema after cataract extraction. Arch Ophthalmol 1976; 94: 793–800.
2.
Witkin AJ, Ko TH, Fujimoto JG, Schuman JS, Baumal CR, Rogers AH, Reichel E, Duker JS: Redefining lamellar holes and the vitreomacular interface: an ultrahigh-resolution optical coherence tomography study. Ophthalmology 2006; 113: 388–397.
3.
Duker JS, Kaiser PK, Binder S, de Smet MD, Gaudric A, Reichel E, Sadda SR, Sebag J, Spaide RF, Stalmans P: The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 2013; 120: 2611–2619.
4.
Pang CE, Spaide RF, Freund KB: Comparing functional and morphologic characteristics of lamellar macular holes with and without lamellar hole-associated epiretinal proliferation. Retina 2015; 35: 720–726.
5.
Parolini B, Schumann RG, Cereda MG, Haritoglou C, Pertile G: Lamellar macular hole: a clinicopathologic correlation of surgically excised epiretinal membranes. Invest Ophthalmol Vis Sci 2011; 52: 9074–9083.
6.
Witkin AJ, Castro LC, Reichel E, Rogers AH, Baumal CR, Duker JS: Anatomic and visual outcomes of vitrectomy for lamellar macular holes. Ophthalmic Surg Lasers Imaging 2010; 41: 418–424.
7.
Androudi S, Stangos A, Brazitikos PD: Lamellar macular holes: tomographic features and surgical outcome. Am J Ophthalmol 2009; 148: 420–426.
8.
Casparis H, Bovey EH: Surgical treatment of lamellar macular hole associated with epimacular membrane. Retina 2011; 31: 1783–1790.
9.
Garretson BR, Pollack JS, Ruby AJ, Drenser KA, Williams GA, Sarrafizadeh R: Vitrectomy for a symptomatic lamellar macular hole. Ophthalmology 2008; 115: 884–886 e1.
10.
Choi WS, Merlau DJ, Chang S: Vitrectomy for macular disorders associated with lamellar macular hole epiretinal proliferation. Retina 2017, DOI: 10.1097/IAE.0000000000001591.
11.
Pang CE, Spaide RF, Freund KB: Epiretinal proliferation seen in association with lamellar macular holes: a distinct clinical entity. Retina 2014; 34: 1513–1523.
12.
Compera D, Entchev E, Haritoglou C, Scheler R, Mayer WJ, Wolf A, Kampik A, Schumann RG: Lamellar hole-associated epiretinal proliferation in comparison to epiretinal membranes of macular pseudoholes. Am J Ophthalmol 2015; 160: 373–384.e1.
13.
Lai TT, Chen SN, Yang CM: Epiretinal proliferation in lamellar macular holes and full-thickness macular holes: clinical and surgical findings. Graefes Arch Clin Exp Ophthalmol 2016; 254: 629–638.
14.
Ko J, Kim GA, Lee SC, Lee J, Koh HJ, Kim SS, Byeon SH, Lee CS: Surgical outcomes of lamellar macular holes with and without lamellar hole-associated epiretinal proliferation. Acta Ophthalmol 2017; 95:e221–e226.
15.
Son G, Lee JS, Lee S, Sohn J: Epiretinal proliferation associated with macular hole and intraoperative perifoveal crown phenomenon. Korean J Ophthalmol 2016; 30: 399–409.
16.
Schumann RG, Compera D, Schaumberger MM, Wolf A, Fazekas C, Mayer WJ, Kampik A, Haritoglou C: Epiretinal membrane characteristics correlate with photoreceptor layer defects in lamellar macular holes and macular pseudoholes. Retina 2015; 35: 727–735.
17.
dell’Omo R, Virgili G, Rizzo S, De Turris S, Coclite G, Giorgio D, dell’Omo E, Costagliola C: Role of lamellar hole-associated epiretinal proliferation in lamellar macular holes. Am J Ophthalmol 2017; 175: 16–29.
18.
Compera D, Schumann RG, Cereda MG, Acquistapace A, Lita V, Priglinger SG, Staurenghi G, Bottoni F: Progression of lamellar hole-associated epiretinal proliferation and retinal changes during long-term follow-up. Br J Ophthalmol 2018; 102: 84–90.
19.
Bottoni F, Deiro AP, Giani A, Orini C, Cigada M, Staurenghi G: The natural history of lamellar macular holes: a spectral domain optical coherence tomography study. Graefes Arch Clin Exp Ophthalmol 2013; 251: 467–475.
20.
Govetto A, Dacquay Y, Farajzadeh M, Platner E, Hirabayashi K, Hosseini H, Schwartz SD, Hubschman JP: Lamellar macular hole: two distinct clinical entities? Am J Ophthalmol 2016; 164: 99–109.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.